ES2333574B1 - COMPOSITE FOR THE TREATMENT OF SKIN IRRITATIONS. - Google Patents
COMPOSITE FOR THE TREATMENT OF SKIN IRRITATIONS. Download PDFInfo
- Publication number
- ES2333574B1 ES2333574B1 ES200801865A ES200801865A ES2333574B1 ES 2333574 B1 ES2333574 B1 ES 2333574B1 ES 200801865 A ES200801865 A ES 200801865A ES 200801865 A ES200801865 A ES 200801865A ES 2333574 B1 ES2333574 B1 ES 2333574B1
- Authority
- ES
- Spain
- Prior art keywords
- compound
- composition
- treatment
- skin
- emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 11
- 230000036556 skin irritation Effects 0.000 title claims abstract description 8
- 239000002131 composite material Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- 206010040880 Skin irritation Diseases 0.000 claims abstract description 7
- 231100000475 skin irritation Toxicity 0.000 claims abstract description 7
- 235000013871 bee wax Nutrition 0.000 claims abstract description 5
- 239000012166 beeswax Substances 0.000 claims abstract description 5
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 5
- 239000000944 linseed oil Substances 0.000 claims abstract description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 4
- 229940042585 tocopherol acetate Drugs 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 18
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 4
- 239000012071 phase Substances 0.000 claims description 4
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 3
- 102000002322 Egg Proteins Human genes 0.000 claims description 3
- 108010000912 Egg Proteins Proteins 0.000 claims description 3
- 235000011399 aloe vera Nutrition 0.000 claims description 3
- 235000013345 egg yolk Nutrition 0.000 claims description 3
- 210000000991 chicken egg Anatomy 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- 229930014626 natural product Natural products 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 244000186892 Aloe vera Species 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 6
- 208000003251 Pruritus Diseases 0.000 abstract description 5
- 230000007803 itching Effects 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 210000002969 egg yolk Anatomy 0.000 abstract description 3
- 239000006071 cream Substances 0.000 abstract description 2
- 239000005445 natural material Substances 0.000 abstract description 2
- 230000000699 topical effect Effects 0.000 abstract description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 239000003883 ointment base Substances 0.000 description 4
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 235000016337 monopotassium tartrate Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 244000183870 Eryngium campestre Species 0.000 description 1
- 235000007810 Eryngium campestre Nutrition 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 206010040840 Skin erosion Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229960000711 alprostadil Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- GNHOJBNSNUXZQA-UHFFFAOYSA-J potassium aluminium sulfate dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GNHOJBNSNUXZQA-UHFFFAOYSA-J 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000001296 salvia officinalis l. Substances 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Reproductive Health (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Compuesto para el tratamiento de las irritaciones de la piel, la invención se refiere a un compuesto integrado esencialmente por sustancias y productos naturales: yema de huevo; aceite de linaza, manteca de cerdo y cera de abejas con pequeña participación de componente químico de influencia tópica intrascendente: BHT; fenonip; alo vera y tocoferol acetato; especialmente destinada a la elaboración de una crema de aplicación externa sobre la piel, especialmente recomendada para hidratar y aliviar las zonas delicadas de la piel en caso de intenso picor o escozor.Compound for the treatment of skin irritations, the invention relates to a compound consisting essentially of natural substances and products: yolk of egg; Flaxseed oil, lard and beeswax with small participation of chemical component of topical influence inconsequential: BHT; fenonip; alo vera and tocopherol acetate; especially intended for the preparation of an application cream external on the skin, especially recommended to moisturize and relieve delicate areas of the skin in case of intense itching or stinging.
Description
Compuesto para el tratamiento de las irritaciones de la piel.Compound for the treatment of skin irritations
La invención se refiere como el enunciado indica a un compuesto integrado esencialmente por sustancias y productos naturales con una pequeña participación de algún componente químico de influencia tópica intrascendente y especialmente destinada a la elaboración de una crema de aplicación externa sobre la piel.The invention is referred to as the statement indicates to a compound consisting essentially of substances and products natural with a small share of some chemical component of inconsequential topical influence and especially for the Preparation of an external application cream on the skin.
El objeto del invento está especialmente recomendada para hidratar y aliviar las zonas delicadas de la piel en caso de intenso picor o escozor.The object of the invention is especially Recommended to moisturize and relieve delicate skin areas in case of intense itching or stinging.
En general, en cualquier zona de la piel irritada que produzca molestias, escozor o picores.In general, in any area of the skin irritated that causes discomfort, stinging or itching.
Sobre todo, particularmente indicada para aliviar esas molestias en zonas muy delicadas de la piel (genitales externos; zona perianal, ingles o cualquier otra).Above all, particularly suitable for relieve those discomforts in very delicate areas of the skin (genitals external; perianal zone, English or any other).
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
En el Estado de la Técnica destaca el antecedente referido a la patente de los propios inventores ES 2 114 507 que se refiere a: "Compuesto para el tratamiento de las hemorroides" que tiene asimismo una composición a base de productos naturales en los que la integración de estos comprende algunos de los contenidos de la invención con una participación que, en este caso, se ha mejorado sensiblemente.In the State of the Art, the antecedent referred to the patent of the inventors themselves ES 2 114 507 which refers to: "Compound for the treatment of hemorrhoids "which also has a composition based on natural products in which the integration of these includes some of the contents of the invention with a participation that, In this case, it has been significantly improved.
Otras referencias están atribuidas a: WO-9315739 A1 divulga un remedio para heridas o irritaciones de la piel que contiene prostaglandina I2 o E1 y derivados de las mismas.Other references are attributed to: WO-9315739 A1 discloses a wound remedy or skin irritations containing prostaglandin I2 or E1 and derivatives thereof.
EP-581972 A1 divulga una composición dermatológica de azufre y crema de tartar con el 22% en peso de azufres, y un 78% de crema de tartar.EP-581972 A1 discloses a dermatological composition of sulfur and cream of tartar with 22% in weight of sulfur, and 78% cream of tartar.
EP-225832 A1 se refiere a una composición medicamentosa a ser utilizada para el tratamiento de la piel que contiene un aceite natural de origen vegetal hiperoxigenado.EP-225832 A1 refers to a drug composition to be used for the treatment of skin that contains a natural vegetable oil hyperoxygenated
EP-9400857 se refiere a un procedimiento para la obtención de diferentes bálsamos fitoterapeúticos para utilización, entre otros, en el tratamiento dermatológico. Dicho procedimiento supone la realización de una composición a partir de agua de manantial, cera virgen, glicerina esterilizada, esencia de romero y otra tal como tomillo, salvia, espliego, lavanda, eucalipto, cayeput, angélica archanchelica o rosa damascena.EP-9400857 refers to a procedure for obtaining different balms phytotherapeutics for use, among others, in the treatment dermatological. Said procedure involves performing a Composition from spring water, virgin wax, glycerin sterilized, rosemary essence and other such as thyme, sage, lavender, lavender, eucalyptus, cayeput, angelica archanchelica or Rosa Damascena.
ES 8900121 A1 divulga un procedimiento para la
preparación de composiciones para la reducción de las flebectasias
en el que se produce la mezcla de sulfato potásico alumínico
dodecahidrato con una base ungüental, hidrofilica, una base
ungüental glicerólica, una base ungüental estearínica o una base
ungüental aniónica hidrofilica
adecuadas.ES 8900121 A1 discloses a process for the preparation of compositions for the reduction of phlebectasias in which the mixture of aluminum potassium sulfate dodecahydrate with an ointment base, hydrophilic, a glycerol ointment base, a stearin ointment base or an anionic ointment base is produced hydrophilic
adequate.
ES 533529 se refiere a una composición para limpiar y frotar la piel, con aceite de yoyoba, escualeno y tri-2-etil-hezanoato de glicerilo, sobre un soporte.ES 533529 refers to a composition for clean and rub the skin, with yoyoba oil, squalene and tri-2-ethyl-hezanoate of glyceryl, on a support.
ES 528601 se refiere a un antidermatológico basado en un extracto de Eryngium campestre L. en aceite de oliva.ES 528601 refers to an antidermatological based on an extract of Eryngium campestre L. in oil olive.
Otras técnicas conocidas consisten en ungüetos o pomadas de contenido químico que tienen como función la de reducir las inflamaciones que se producen alrededor de la irritación o de los propios puntos afectados al asomar con el consiguiente efecto álgico, además de las técnicas quirúrgicas o los dispositivos de colocación en evitación de dolores y molestias.Other known techniques consist of ogüetos or chemical ointments that have the function of reducing the inflammations that occur around the irritation or the affected points themselves when they appear with the consequent effect allergic, in addition to surgical techniques or devices placement in avoidance of pain and discomfort.
La presente invención tiene por objeto un compuesto para el tratamiento de las irritaciones de la piel, que mejora cualesquiera de los tratamientos anteriores conocidos, incluso el propio de los inventores, favoreciendo una rápida y eficaz desaparición de los síntomas, picores, escozores, dolores y similares.The present invention aims at a compound for the treatment of skin irritations, which improve any of the previous known treatments, even the inventors own, favoring a quick and effective disappearance of symptoms, itching, stinging, pain and Similar.
\newpage\ newpage
Consiste en la preparación de un compuesto integrado por la mezcla de diversas sustancias naturales principalmente y en el porcentaje cualitativo siguiente:It consists in the preparation of a compound composed of the mixture of various natural substances mainly and in the following qualitative percentage:
Los porcentajes hacen referencia a la composición final del producto objeto de la invención y, según la cantidad que se tenga que elaborar, la participación cuantitativa será proporcional a dicho porcentaje en el que, para la elaboración de 100 kg de compuesto integración sería de:The percentages refer to the final composition of the product object of the invention and, according to the amount to be prepared, quantitative participation will be proportional to said percentage in which, for the elaboration 100 kg of integration compound would be:
15,00 kg. de yema de huevo (de gallina).15.00 kg of egg yolk (of chicken).
7,50 kg. de aceite de linaza7.50 kg linseed oil
73,78 kg. de manteca de cerdo73.78 kg lard
2,00 kg. de cera de abejas2.00 kg beeswax
0,02 Kg BHT0.02 Kg BHT
0,20 kg Fenonip0.20 kg Fenonip
0,50 kg Aloe vera0.50 kg Aloe Vera
1,00 kg Tocoferol acetato1.00 kg Tocopherol acetate
Consiste en la disposición mezclada de yema de huevo previamente calentada a una temperatura de disolución a la que se añade la manteca de cerdo y el aceite de linaza, así como la cera de abeja, el BHT, el Fenonip y la aloe vera por este orden formándose con ello una emulsión que adquiere consistencia por el batido lento, cíclico uniforme y regular en velocidad y sentido de la composición. Esta se dispone en un espacio a una temperatura apropiada para condensación aislada del ambiente, no conociéndose los efectos producidos fuera de este posible rango de temperaturas. La aplicación se realiza directamente sobre el lugar afectado de la piel.It consists of the mixed arrangement of yolk of previously heated egg at a dissolution temperature at that is added the lard and the linseed oil, as well as the beeswax, BHT, Fenonip and aloe vera in this order thereby forming an emulsion that acquires consistency by the slow, uniform and regular cyclic smoothie in speed and sense of the composition. This is arranged in a space at a temperature suitable for condensation isolated from the environment, not knowing the effects produced outside this possible temperature range. The application is made directly on the affected place of the skin.
Se dispone de una cantidad en peso directamente proporcional al porcentaje cualitativo desarrollado en la correspondiente fórmula citada anteriormente en la que se requiere el precalentamiento de la casi totalidad de la composición, más concretamente de la yema de huevo de gallina, del aceite de linaza, de la manteca de cerdo, cera de abeja, BHT y Fenonip, facilitando la emulsión el hecho de añadir los componentes en el orden señalado, calentándolos a una temperatura de 55º-60ºC hasta total fusión de los mismos en estado sólido.A quantity by weight is available directly proportional to the qualitative percentage developed in the corresponding formula cited above in which it is required the preheating of almost the entire composition, more specifically chicken egg yolk, flaxseed oil, of lard, beeswax, BHT and Fenonip, facilitating the emulsion adding the components in the order indicated, heating them at a temperature of 55º-60ºC until total melting them in solid state.
Se observa la emulsión hasta la fase líquida y una vez tenemos los componentes líquidos se procede a añadir la séptima fase o ingrediente de aloe vera hasta total disolución.The emulsion is observed until the liquid phase and once we have the liquid components we proceed to add the seventh phase or ingredient of aloe vera until completely dissolved.
Llegados a la total disolución referida se apagan las fuentes de calor y con agitación continua esperamos a que la temperatura disminuya, con preferencia a 40ºC, y en ese momento incorporamos la fase octava añadiendo por tanto el ingrediente de Tocoferol Acetato sin dejar de agitar y obtenida la composición se envasará en caliente. La composición está en disposición de ser utilizada una vez homogeneizada y enfriada la mezcla.Arrived at the total dissolution referred to turn off the heat sources and with continuous agitation we wait for that the temperature decrease, preferably at 40 ° C, and in that moment we enter the eighth phase thus adding the ingredient of Tocopherol Acetate while stirring and obtained the Composition will be hot packed. The composition is in disposition to be used once homogenized and cooled the mixture.
Es susceptible de aplicación industrial para el tratamiento de las irritaciones o erosiones de la piel, picores, escozores y similares.It is capable of industrial application for treatment of skin irritations or erosions, itching, stinging and the like.
Una vez descrita convenientemente la naturaleza del invento se hace constar a los efectos oportunos, que el mismo no queda limitado a los detalles exactos de esta exposición, sino que por contrario, en él se introducirán las modificaciones que se consideran oportunas, siempre que no se alteren las características esenciales del mismo, que se reivindican a continuación.Once nature is conveniently described of the invention is recorded for the appropriate purposes, that the same It is not limited to the exact details of this exhibition, but that on the contrary, it will introduce the modifications that are they consider appropriate, provided that the characteristics are not altered Essentials thereof, which are claimed below.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200801865A ES2333574B1 (en) | 2008-06-23 | 2008-06-23 | COMPOSITE FOR THE TREATMENT OF SKIN IRRITATIONS. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200801865A ES2333574B1 (en) | 2008-06-23 | 2008-06-23 | COMPOSITE FOR THE TREATMENT OF SKIN IRRITATIONS. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2333574A1 ES2333574A1 (en) | 2010-02-23 |
| ES2333574B1 true ES2333574B1 (en) | 2010-11-04 |
Family
ID=41727358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200801865A Expired - Fee Related ES2333574B1 (en) | 2008-06-23 | 2008-06-23 | COMPOSITE FOR THE TREATMENT OF SKIN IRRITATIONS. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2333574B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL229836A0 (en) | 2013-12-08 | 2014-03-31 | Y & B Mother S Choice Ltd | Preparations for suppressing or attenuating ocular irritancy |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB190103513A (en) * | 1901-02-19 | 1901-11-23 | Frederick Jermyn Smith | An Improved Remedy in Salve or Composition for Healing External Complaints of Human Body & Animal Diseases |
| GB190719133A (en) * | 1907-08-26 | 1908-05-07 | William Bryant | An Improved Ointment |
| GB318661A (en) * | 1928-06-07 | 1929-09-09 | Matthew Lyons | Medicinal ointment and process of manufacturing same |
| CA1263605A (en) * | 1987-12-02 | 1989-12-05 | Ginger Osterfeld | Pitch salve |
| ES2114507B1 (en) * | 1996-11-14 | 1999-02-01 | Martinez Conchell Francisco | COMPOUND FOR THE TREATMENT OF HEMORRHOIDS. |
| EP0985404A1 (en) * | 1998-02-10 | 2000-03-15 | Shiseido Company Limited | Oil-in-water type emulsified compositions |
-
2008
- 2008-06-23 ES ES200801865A patent/ES2333574B1/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB190103513A (en) * | 1901-02-19 | 1901-11-23 | Frederick Jermyn Smith | An Improved Remedy in Salve or Composition for Healing External Complaints of Human Body & Animal Diseases |
| GB190719133A (en) * | 1907-08-26 | 1908-05-07 | William Bryant | An Improved Ointment |
| GB318661A (en) * | 1928-06-07 | 1929-09-09 | Matthew Lyons | Medicinal ointment and process of manufacturing same |
| CA1263605A (en) * | 1987-12-02 | 1989-12-05 | Ginger Osterfeld | Pitch salve |
| ES2114507B1 (en) * | 1996-11-14 | 1999-02-01 | Martinez Conchell Francisco | COMPOUND FOR THE TREATMENT OF HEMORRHOIDS. |
| EP0985404A1 (en) * | 1998-02-10 | 2000-03-15 | Shiseido Company Limited | Oil-in-water type emulsified compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2333574A1 (en) | 2010-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2998817T3 (en) | Topical formulations comprising cannabidiol, method of preparing the composition and use thereof | |
| ES2576832T3 (en) | Use of an oleogel containing triterpenes for healing | |
| ES2796724T3 (en) | Composition based on natural vegetable oil and lime water | |
| ES2412010B1 (en) | Topical medication for the treatment of psoriasis | |
| ES2333574B1 (en) | COMPOSITE FOR THE TREATMENT OF SKIN IRRITATIONS. | |
| ES2379474T3 (en) | Dermatological product for the treatment and / or skin care with neurodermitis | |
| RU2211026C1 (en) | Skin care cosmetic agent with wound-healing effect (balsam "aidas") | |
| Hamid et al. | Formulation and evaluation of benzyl benzoate emulgel | |
| ES2365283B1 (en) | SYRUP OF HONEY AND METHOD FOR THEIR ELABORATION. | |
| ES2409353T3 (en) | Dermatological composition for the treatment of bedsores | |
| RU2078560C1 (en) | Skin creme "pasechny" | |
| US20140127315A1 (en) | Caudal Salve | |
| RU2211025C1 (en) | Cosmetic agent with heating effect (massage cream, balsam "aidas" b) | |
| ES2211341B1 (en) | COMPOSITIONS CONTAINING OZONIZED NATURAL OILS. | |
| RU2478368C2 (en) | Ointment for treatment in case of frostbites | |
| AU2015233102B2 (en) | Composition comprising bee products | |
| ES2396075B1 (en) | COSMETIC COMPOSITION OF TOPICAL ADMINISTRATION. | |
| ES2362066B1 (en) | COMBINED PREPARATION FOR THE TREATMENT OF PSORIASIS. | |
| ES2440649T3 (en) | Treatment of menopausal symptoms with new indication for myrrh | |
| ES2601249B1 (en) | PROCESS OF ELABORATION OF SANITARY CREAM AND RESULTING PRODUCT | |
| ES2657828A2 (en) | PRODUCT, OR ACTIVE AGENT, OR COMPOSITION FOR THE CARE OF THE BREASTS IN PRE-MENSTRUAL OR MENSTRUAL PERIOD OR FOR THE CARE OF THE SYMPTOMATOLOGY OF THE MASTODINIAS (Machine-translation by Google Translate, not legally binding) | |
| ES2613888B1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALOPECIA | |
| RU2120791C1 (en) | Cream "apirel" | |
| US20180028424A1 (en) | Compositions for improving the health of hair, skin, and nails | |
| ES1299174U (en) | COSMETIC CREAM FOR TOPICAL APPLICATION ON THE SKIN (Machine-translation by Google Translate, not legally binding) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2333574B1 Country of ref document: ES |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20181011 |